UBS Maintains a 'Buy' on Cardinal Health (CAH); Expect EPS Upside Near- & Long-Term
Tweet Send to a Friend
UBS maintains a 'Buy' on Cardinal Health (NYSE: CAH), raises price target from $40 to $43.
UBS ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
